HYTN Innovations

HYTN Innovations Inc (CSE:HYTN), a leader in the development and manufacture of psychoactive and psychotropic compounds, including cannabis and psilocybin, has completed the acquisition of Prism Scientific Labs Inc, as announced in their July 19 press release. This strategic move is intended to...

HYTN Innovations Inc. (CSE:HYTN) has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances Act. The has installed equipment at its Kelowna facility, including high-performance...

HYTN Cannabis Inc. wholly owned subsidiary of HYTN Innovations Inc., (CSE:HYTN) has developed and listed for sale its all-new Nano Gummies product. The Nano Gummies, complement the company’s current offering of all-natural, sugar and sweetener-free sparkling cannabis beverages. According to...

HYTN Cannabis Inc., wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has been awarded a license by Health Canada allowing for the sale of cannabis for medical purposes. This follows a list of license achievements including a standard processing license, cannabis research license, an...